Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-02

FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (WALGREEN COMPANY)

View source ↗

Summary

FDA approved Walgreens' supplemental application for Guaifenesin and Pseudoephedrine Hydrochloride, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE (guaifenesin and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE (GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE)